- Filed
- Mar 27, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2024 · Mar 24, 2025 | 2.81M sh |
| Capex | FY 2024 · Dec 31, 2024 | $0 |
| Capex | FY 2024 · Dec 31, 2023 | $51K |
| Sga Expense | FY 2024 · Dec 31, 2024 | $12.58M |
| Sga Expense | FY 2024 · Dec 31, 2023 | $12.99M |
| Shares Diluted | FY 2024 · Dec 31, 2023 | 2.87M sh |
| Stock Repurchased | FY 2024 · Dec 31, 2023 | $62K |
| Operating Cash Flow | FY 2024 · Dec 31, 2023 | $1.68M |
| Short Term Investments | FY 2024 · Dec 31, 2023 | $4.37M |
| Cash And Equivalents | FY 2024 · Dec 31, 2023 | $10.25M |
| Stockholders Equity | FY 2024 · Dec 31, 2023 | $32.44M |
| Total Liabilities | FY 2024 · Dec 31, 2023 | $9.48M |
| Total Assets | FY 2024 · Dec 31, 2023 | $41.9M |
| Eps Diluted | FY 2024 · Dec 31, 2023 | −$0.29 |
| Eps Basic | FY 2024 · Dec 31, 2023 | −$0.29 |
| Net Income | FY 2024 · Dec 31, 2023 | −$822K |
| Gross Profit | FY 2024 · Dec 31, 2023 | $10.53M |
| Cost Of Revenue | FY 2024 · Dec 31, 2023 | $575K |
| Revenue | FY 2024 · Dec 31, 2023 | $11.11M |